PP1 catalytic isoforms are differentially expressed and regulated in human prostate cancer

Targeting the androgen receptor and overcoming resistance in prostate cancer

(2019) David J. Einstein et al.   CURRENT OPINION IN ONCOLOGY

Amelioration of obsessive-compulsive disorder in three mouse models treated with one epigenetic drug: unraveling the underlying mechanism

(2019) German Todorov et al.   Scientific Reports

Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly

(2019) Qing Shi et al.   Molecular Cancer

Deregulated PP1α phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism

(2018) Ming Chen et al.   Nature Communications

Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer

(2018) Sónia Carvalho et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

COSMIC: the Catalogue Of Somatic Mutations In Cancer

(2018) John G Tate et al.   NUCLEIC ACIDS RESEARCH

Integrative clinical genomics of metastatic cancer

(2017) Dan R. Robinson et al.   NATURE

Actomyosin drives cancer cell nuclear dysmorphia and threatens genome stability

(2017) Tohru Takaki et al.   Nature Communications

Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer

(2017) Eva M. Verdugo-Sivianes et al.   Oncotarget

Differential regulation of the androgen receptor by protein phosphatase regulatory subunits

(2017) James Grey et al.   Oncotarget

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

(2017) Darshan S. Chandrashekar et al.   NEOPLASIA

A novel rasopathy caused by recurrent de novo missense mutations inPPP1CBclosely resembles Noonan syndrome with loose anagen hair

(2016) Karen W. Gripp et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma

(2016) Chunsun Li et al.   DIGESTIVE DISEASES AND SCIENCES

De novo missense variants in PPP1CB are associated with intellectual disability and congenital heart disease

(2016) Lijiang Ma et al.   HUMAN GENETICS

Protein phosphatase 1γ regulates the proliferation of human glioma via the NF-κB pathway

(2016) ZHEN BAO et al.   ONCOLOGY REPORTS

Androgen ablation elicits PP1-dependence for AR stabilization and transactivation in prostate cancer

(2016) Xiaming Liu et al.   PROSTATE

The Molecular Taxonomy of Primary Prostate Cancer

(2015) Adam Abeshouse et al.   CELL

Nuclear Protein Phosphatase 1 α (PP1A) Expression is Associated with Poor Prognosis in p53 Expressing Glioblastomas

(2015) Arun H. Shastry et al.   PATHOLOGY & ONCOLOGY RESEARCH

Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer

(2015) Katarina Davalieva et al.   PROSTATE

Protein phosphatase 1 suppresses androgen receptor ubiquitylation and degradation

(2015) Xiaming Liu et al.   Oncotarget

Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts

(2015) Diana Mesquita et al.   Oncotarget

AR-v7 protein expression is regulated by protein kinase and phosphatase

(2015) Yinan Li et al.   Oncotarget

Phosphoprotein Phosphatase 1 Complexes in Spermatogenesis

(2015) Joana Silva et al.   Current Molecular Pharmacology

Protein Phosphatase 1 and Its Complexes in Carcinogenesis

(2014) Joao Figueiredo et al.   CURRENT CANCER DRUG TARGETS

Protein phosphatase 1 catalytic isoforms: specificity toward interacting proteins

(2014) Luís Korrodi-Gregório et al.   Translational Research

De Novo Mutations in Moderate or Severe Intellectual Disability

(2014) Fadi F. Hamdan et al.   PLoS Genetics

The Mutational Landscape of Prostate Cancer

(2013) Christopher E. Barbieri et al.   EUROPEAN UROLOGY

ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients

(2013) E. Baena et al.   GENES & DEVELOPMENT

The Cancer Genome Atlas Pan-Cancer analysis project

(2013) John N Weinstein et al.   NATURE GENETICS

Cocaine represses protein phosphatase-1Cβ through DNA methylation and Methyl-CpG Binding Protein-2 recruitment in adult rat brain

(2013) Sarah Pol Bodetto et al.   NEUROPHARMACOLOGY

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

(2013) J. Gao et al.   Science Signaling

PP-1α and PP-1γ Display Antagonism and Differential Roles in Tumorigenicity of Lung Cancer Cells

(2012) P.-C. Chen et al.   CURRENT MOLECULAR MEDICINE

p21-activated Kinase 6 (PAK6) Inhibits Prostate Cancer Growth via Phosphorylation of Androgen Receptor and Tumorigenic E3 Ligase Murine Double Minute-2 (Mdm2)

(2012) Tong Liu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

Glioblastoma-Specific Protein Interaction Network Identifies PP1A and CSK21 as Connecting Molecules between Cell Cycle-Associated Genes

(2010) J. Ladha et al.   CANCER RESEARCH

Testing mutual exclusivity of ETS rearranged prostate cancer

(2010) Maria A Svensson et al.   LABORATORY INVESTIGATION

Androgen Receptor Phosphorylation and Activity Are Regulated by an Association with Protein Phosphatase 1

(2009) Shaoyong Chen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteins

(2008) Ramneet Kaur et al.   PROSTATE